Olek Elizabeth A 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Jan 11, 2012
Insider Transaction Report
Form 4
Olek Elizabeth A
Vice President and CMO
Transactions
- Sale
Common Stock
2012-01-10$10.06/sh−12,468$125,428→ 2,000 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-01-10−12,468→ 20,782 totalExercise: $3.28Exp: 2019-12-18→ Common Stock (12,468 underlying) - Exercise/Conversion
Common Stock
2012-01-10$3.28/sh+12,468$40,895→ 14,468 total
Footnotes (1)
- [F1]This option was granted on December 18, 2009 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.